@article{AdemKueteMbavengetal.2018,
  author    = {Adem, Fozia A. and Kuete, Victor and Mbaveng, Armelle T. and Heydenreich, Matthias and Ndakala, Albert and Irungu, Beatrice and Efferth, Thomas and Yenesew, Abiy},
  title     = {Cytotoxic benzylbenzofuran derivatives from Dorstenia kameruniana},
  series = {Fitoterapia},
  volume    = {128},
  journal   = {Fitoterapia},
  publisher = {Elsevier},
  address   = {Amsterdam},
  issn      = {0367-326X},
  doi       = {10.1016/j.fitote.2018.04.019},
  pages     = {26 -- 30},
  year      = {2018},
  abstract  = {Chromatographic separation of the extract of the roots of Dorstenia kameruniana (family Moraceae) led to the isolation of three new benzylbenzofuran derivatives, 2-(p-hydroxybenzyl)benzofuran-6-ol (1), 2-(p-hydroxybenzyl)-7-methoxybenzofuran-6-ol (2) and 2-(p-hydroxy)-3-(3-methylbut-2-en-1-yl)benzyl)benzofuran-6-ol (3) (named dorsmerunin A, B and C, respectively), along with the known furanocoumarin, bergapten (4). The twigs of Dorstenia kameruniana also produced compounds 1-4 as well as the known chalcone licoagrochalcone A (5). The structures were elucidated by NMR spectroscopy and mass spectrometry. The isolated compounds displayed cytotoxicity against the sensitive CCRF-CEM and multidrug-resistant CEM/ADR5000 leukemia cells, where compounds 4 and 5 had the highest activities (IC50 values of 7.17 mu M and 5.16 mu M, respectively) against CCRF-CEM leukemia cells. Compound 5 also showed cytotoxicity against 7 sensitive or drug-resistant solid tumor cell lines (breast carcinoma, colon carcinoma, glioblastoma), with IC50 below 50 mu M, whilst 4 showed selective activity.},
  language  = {en}
}